206 related articles for article (PubMed ID: 35490316)
1. Identification of Six Novel Prognostic Gene Signatures as Potential Biomarkers in Small Cell Lung Cancer.
Feng S; Zhang X; Gu X; Zhou M; Chen Y; Wang C
Comb Chem High Throughput Screen; 2023; 26(5):938-949. PubMed ID: 35490316
[TBL] [Abstract][Full Text] [Related]
2. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
3. Identification of Immune Infiltration and Prognostic Biomarkers in Small Cell Lung Cancer Based on Bioinformatic Methods from 3 Studies.
Cao J; Yu C
Comb Chem High Throughput Screen; 2023; 26(3):507-516. PubMed ID: 35400336
[TBL] [Abstract][Full Text] [Related]
4. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
[TBL] [Abstract][Full Text] [Related]
5. The identification of a two-gene prognostic model based on cisplatin resistance-related ceRNA network in small cell lung cancer.
Zhang Y; Zhu Q; Qi J; Fu M; Xu A; Wang W; Wang H; Nie J; Hong B
BMC Med Genomics; 2023 May; 16(1):103. PubMed ID: 37189142
[TBL] [Abstract][Full Text] [Related]
6. Establishment and validation of a novel autophagy-related gene signature for patients with breast cancer.
Du JX; Chen C; Luo YH; Cai JL; Cai CZ; Xu J; Ni XJ; Zhu W
Gene; 2020 Dec; 762():144974. PubMed ID: 32707305
[TBL] [Abstract][Full Text] [Related]
7. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
8. A Novel Hypoxia-Related Gene Signature with Strong Predicting Ability in Non-Small-Cell Lung Cancer Identified by Comprehensive Profiling.
Yang H; Wang Z; Gong L; Huang G; Chen D; Li X; Du F; Lin J; Yang X
Int J Genomics; 2022; 2022():8594658. PubMed ID: 35634481
[TBL] [Abstract][Full Text] [Related]
9. Identification of Key Biomarkers and Pathways in Small-Cell Lung Cancer Using Biological Analysis.
Liu H; Li T; Ye X; Lyu J
Biomed Res Int; 2021; 2021():5953386. PubMed ID: 34712733
[TBL] [Abstract][Full Text] [Related]
10. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis.
Reyimu A; Chen Y; Song X; Zhou W; Dai J; Jiang F
World J Surg Oncol; 2021 Aug; 19(1):240. PubMed ID: 34384424
[TBL] [Abstract][Full Text] [Related]
11. Common and distinct features of potentially predictive biomarkers in small cell lung carcinoma and large cell neuroendocrine carcinoma of the lung by systematic and integrated analysis.
Dong S; Liang J; Zhai W; Yu Z
Mol Genet Genomic Med; 2020 Mar; 8(3):e1126. PubMed ID: 31981472
[TBL] [Abstract][Full Text] [Related]
12. Identification and validation of autophagy-related gene expression for predicting prognosis in patients with idiopathic pulmonary fibrosis.
Huang G; Xu X; Ju C; Zhong N; He J; Tang XX
Front Immunol; 2022; 13():997138. PubMed ID: 36211385
[TBL] [Abstract][Full Text] [Related]
13. Construction of Prognostic Risk Model for Small Cell Lung Cancer Based on Immune-Related Genes.
Deng F; Tao F; Xu Z; Zhou J; Gong X; Zhang R
Comput Math Methods Med; 2022; 2022():7116080. PubMed ID: 36245844
[TBL] [Abstract][Full Text] [Related]
14. Prognostic biomarkers and immune cell infiltration characteristics in small cell lung cancer.
Ni J; Si X; Wang H; Zhang X; Zhang L
Cancer Pathog Ther; 2023 Jan; 1(1):18-24. PubMed ID: 38328611
[TBL] [Abstract][Full Text] [Related]
15. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
Xu HH; Wang HL; Xing TJ; Wang XQ
Front Immunol; 2022; 13():851622. PubMed ID: 35924232
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analyses of N
Luo Y; Zhang Z; Zheng B; Wu P; Zhang G; Wang L; Zeng Q; Yang Z; Xue L; Zeng H; Tan F; Xue Q; Gao S; Sun N; He J
Cancer Sci; 2022 Dec; 113(12):4289-4299. PubMed ID: 36047973
[TBL] [Abstract][Full Text] [Related]
17. Analysis of genes associated with prognosis of lung adenocarcinoma based on GEO and TCGA databases.
Yu Y; Tian X
Medicine (Baltimore); 2020 May; 99(19):e20183. PubMed ID: 32384511
[TBL] [Abstract][Full Text] [Related]
18. Identification of potential target genes and crucial pathways in small cell lung cancer based on bioinformatic strategy and human samples.
Chen X; Wang L; Su X; Luo SY; Tang X; Huang Y
PLoS One; 2020; 15(11):e0242194. PubMed ID: 33186389
[TBL] [Abstract][Full Text] [Related]
19. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
20. [Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma].
Zhou J; Wang X; Li Z; Jiang R
Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):557-566. PubMed ID: 34256900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]